Biliverdin and heme oxygenase antiviral activity against hepatitis C virus

Annals of Hepatology

Volumn 10, Issue 1, 2011, Pages 105-107

  Gutiérrez Grobe, Ylse ^a   Vitek, Libor ^b   Tiribelli, Claudio ^c   Kobashi Margáin, Ramón A ^a   Uribe, Misael ^a   Méndez Sánchez, Nahum ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BILIVERDIN; HEME OXYGENASE; VIRUS DNA; VIRUS PROTEIN;

ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG TARGETING; ENERGY TRANSFER; ENZYME INHIBITION; HEPATITIS C VIRUS; HUMAN; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPLICON; VIRUS REPLICATION;

EID: 79955994008     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31598-4     Document Type: Article

References (16)

1. Zhu Z, Wilson AT, Luxon BA, Brown KE, Mathahs MM, Bandyopadhyay S, et al. Biliverdin Inhibits Hepatitis C Virus Nonstructural 3/4A Protease Activity: Mechanism for the Antiviral Effects of Heme Oxygenase? Hepatology 2010; 52: 1897-1905.
2. Zhu Z, Wilson AT, Mathans MM, Wen F, Brown KE, Luxon BA et al. Heme oxygenase-1 supresses hepatitis C rivus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 2008; 48: 1430-1439.
3. Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, Benedicto I, Rosado JA, et al. Hepatitis c virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J Hepatol 2009; 50:872-882.
4. Vijayan V, Mueller S, Baumgart-Vogt E, Immenschuh S. Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract. World J Gastroenterol 2010; 16(25): 3112-3119.
5. Shimizu H, Takahashi T, Suzuki T, Yamasaki A, Fujiwara T, Odaka Y, et al. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 2000; 28: 809-817.
6. Aztatzi-Santillán E, Nares-López FE, Márquez-Valadez B, Aguilera P, Chánez-Cárdenas ME. The Protective Role of Heme Oxygenase-1 in Cerebral Ischemia. Cent Nerv Syst Agents Med Chem 2010; 2010; 10(4): 310-316.
7. Öllinger R, Pratschke J. Role of heme oxygenase-1 in transplantation. Transpl Int. 2010; 23(11): 1071-1081.
8. Sass G, Soares MC, Yamashita K, Seyfried S, Zimmermann WH, Eschenhagen T, et al. Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice. Hepatology 2003; 38: 909-918.
9. Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, et al. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 2007; 133: 1156-1165.
10. McPhee F, Caldera PS, Bemis GW, McDonagh AF, Kuntz ID, Craik CS. Bile Pigmentes as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem J. 1996; 320: 681-686.
11. Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007; 43: 1-57.
12. Qin XF. Inactivation of digestive proteases by deconjugated bilirubin: the possible evolutionary driving force for bilirubin or biliverdin predominance in animals. Gut 2007; 56: 1641-1642.
13. Ascenzi P, Fasano M. Heme-hemopexin: a "chronosteric" heme-protein. IUMB Life 2007; 59: 700-708.
14. Miller YI, Shaklai N. Kinetics of hemin distribution in plasma reveals its role in lipoprotein oxidation. Bioch Biophys Acta 1999; 1454: 153-164.
15. McDonagh AF. The biliverdin-bilirubin antioxidant cycle of cellular protection: Missing a wheel? Free Radic Biol Med 2010; 49: 814-820.
16. Bonkovsky HL, Lambrecht RW, Naishadham DN. Genetic variations in heme oxygenase-1 and chronic hepatitis. Hepatology 2010; 52: 401-402.